Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings

Filetype[PDF-32.94 MB]


Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
English
Details You May Also Like

Details:

  • Personal Author:
  • Corporate Authors:
    National Institute for Occupational Safety and Health
  • Description:
    Recent evidence in the Alert summarized on this poster documents that worker exposure to hazardous drugs is a persistent problem. Although most air-sampling studies have not demonstrated significant airborne concentrations of these drugs, the sampling methods used in the past have come into question [Larson et al. 2003] and may not be a good indicator of contamination in the workplace. In all studies involving examination of surface wipe samples, researchers have determined that surface contamination of the workplace is common and widespread. Also, a number of recent studies have documented the excretion of several indicator drugs in the urine of health care workers. Results from studies indicate that worker exposure to hazardous drugs in health care facilities may result in adverse health effects. Appropriately designed studies have begun and are continuing to characterize the extent and nature of health hazards associated with these ongoing exposures. NIOSH is currently conducting studies to further identify potential sources of exposure and methods to reduce or eliminate worker exposure to these drugs. To minimize these potentially acute (short-term) and chronic (long-term) effects of exposure to hazardous drugs at work, NIOSH recommends that at a minimum, employers and health care workers follow the recommendations presented in this Alert. " - NIOSHTIC-2

    Includes bibliographical references (p. 20-30).

  • Content Notes:
    The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated Appendix A in the NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. This list includes drugs reviewed by NIOSH up to June 2007. The current list of hazardous drugs can be found in: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

    This Alert was written by G. Edward Burroughs, Thomas H. Connor, Melissa A. McDiarmid, Kenneth R. Mead, Luci A. Power, and Lawrence D. Reed.

  • Subjects:
  • Series:
  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov